- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
VSee Health, Inc. (VSEE)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
01/09/2026: VSEE (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $5
1 Year Target Price $5
| 0 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -64.12% | Avg. Invested days 19 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 18.07M USD | Price to earnings Ratio 0.93 | 1Y Target Price 5 |
Price to earnings Ratio 0.93 | 1Y Target Price 5 | ||
Volume (30-day avg) 1 | Beta 0.51 | 52 Weeks Range 0.36 - 2.08 | Updated Date 01/9/2026 |
52 Weeks Range 0.36 - 2.08 | Updated Date 01/9/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.46 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -69.81% | Operating Margin (TTM) -51.69% |
Management Effectiveness
Return on Assets (TTM) -25.98% | Return on Equity (TTM) -259.62% |
Valuation
Trailing PE 0.93 | Forward PE - | Enterprise Value 24644738 | Price to Sales(TTM) 1.25 |
Enterprise Value 24644738 | Price to Sales(TTM) 1.25 | ||
Enterprise Value to Revenue 1.71 | Enterprise Value to EBITDA - | Shares Outstanding 33193140 | Shares Floating 24492190 |
Shares Outstanding 33193140 | Shares Floating 24492190 | ||
Percent Insiders 16.1 | Percent Institutions 3.36 |
Upturn AI SWOT
VSee Health, Inc.

Company Overview
History and Background
VSee Health, Inc. is a telepresent robotics company focused on providing remote healthcare solutions. Founded in 2012, the company has been a pioneer in developing and deploying telepresence robots for various medical applications, aiming to bridge geographical gaps in healthcare access. Key milestones include the development of its VSee platform, enabling secure and high-quality video consultations, and the deployment of its robots in numerous hospitals and clinics.
Core Business Areas
- Telepresence Robotics: Design, manufacturing, and deployment of telepresence robots that allow healthcare professionals to remotely interact with patients, conduct virtual rounds, and consult with specialists. These robots are equipped with high-definition cameras, microphones, and displays, enabling a sense of physical presence.
- Telehealth Platform: Development and operation of a secure, HIPAA-compliant telehealth platform that facilitates remote consultations, patient monitoring, and secure data exchange between healthcare providers and patients.
- Remote Patient Monitoring Solutions: Offering solutions for remote monitoring of patients' vital signs and health conditions, integrating with their telehealth platform and robotics for timely interventions.
Leadership and Structure
VSee Health, Inc. is led by a management team with expertise in robotics, healthcare, and technology. Specific leadership roles and the detailed organizational structure are typically proprietary information and not publicly disclosed in granular detail. The company operates with a focus on engineering, sales, and customer support to drive its product development and market penetration.
Top Products and Market Share
Key Offerings
- Competitors: InTouch Health (Teladoc Health),Double Robotics,Ava Robotics
- Product Name 1: VSee Telepresence Robot. This product allows physicians to remotely examine patients, conduct virtual rounds, and consult with other specialists. Market share data for niche telepresence robot markets is not readily available, but VSee is considered a key player in the healthcare segment. Competitors include InTouch Health (now part of Teladoc Health), Double Robotics, and Ava Robotics, though their focus may vary.
- Revenue: Revenue figures for specific products are not publicly disclosed.
- Users: Deployed in hundreds of healthcare facilities globally.
- Competitors: Teladoc Health,Amwell,Doximity
- Product Name 2: VSee Telehealth Platform. A secure, HIPAA-compliant platform for conducting virtual visits, remote patient monitoring, and secure communication. This platform integrates with VSee's robots and other telehealth devices. Market share is difficult to quantify due to the fragmented nature of the telehealth software market, but it competes with established players and emerging telehealth solutions. Competitors include Teladoc Health, Amwell, Doximity, and numerous smaller EHR-integrated solutions.
- Revenue: Revenue figures for specific products are not publicly disclosed.
- Users: Used by thousands of healthcare providers and patients.
Market Dynamics
Industry Overview
The telehealth and telepresence robotics market is experiencing significant growth, driven by factors such as an aging population, increasing demand for convenient healthcare, a shortage of healthcare professionals in remote areas, and advancements in technology. The COVID-19 pandemic significantly accelerated the adoption of telehealth solutions.
Positioning
VSee Health, Inc. is positioned as an innovative provider of integrated telepresence robotics and telehealth solutions specifically tailored for the healthcare industry. Their strength lies in the seamless integration of their physical robots with their robust software platform, offering a comprehensive remote care solution. Their competitive advantage stems from their early entry and specialized focus on healthcare telepresence.
Total Addressable Market (TAM)
The global telehealth market is projected to reach hundreds of billions of dollars in the coming years. The telepresence robotics segment within healthcare is a smaller but rapidly growing niche. VSee Health, Inc. is strategically positioned to capture a significant share of the healthcare telepresence robotics market by offering a specialized and integrated solution.
Upturn SWOT Analysis
Strengths
- Pioneering technology in healthcare telepresence robotics
- Integrated hardware and software platform
- Focus on a specialized and growing market (healthcare)
- Established track record of deployments in medical settings
- HIPAA-compliant platform
Weaknesses
- High upfront cost of telepresence robots can be a barrier for some institutions
- Dependence on technology infrastructure and internet connectivity
- Potential for market saturation with evolving telehealth solutions
- Limited brand recognition compared to larger telehealth giants
Opportunities
- Expansion into new healthcare specialties (e.g., elder care, mental health)
- Partnerships with hospital networks and healthcare systems
- Development of AI-powered features for enhanced remote diagnostics
- International market expansion
- Increasing government support and reimbursement for telehealth services
Threats
- Intensifying competition from established telehealth providers and new entrants
- Regulatory changes affecting telehealth reimbursement and practice
- Rapid technological advancements rendering existing hardware obsolete
- Data security and privacy breaches
- Economic downturns impacting healthcare budgets
Competitors and Market Share
Key Competitors
- Teladoc Health (TDOC)
- Amwell (AMWL)
- AMD (AMD) - indirectly through its technology enabling telehealth
- HP (HPQ) - through its collaboration on telepresence devices
Competitive Landscape
VSee Health, Inc. differentiates itself by offering a specialized telepresence robotics solution integrated with a telehealth platform, focusing on creating a more immersive and effective remote patient interaction. While larger telehealth companies have broader market reach and a wider array of services, VSee's specialized hardware-software integration provides a distinct advantage in specific clinical use cases. Challenges include the higher cost of dedicated telepresence hardware compared to software-only solutions.
Growth Trajectory and Initiatives
Historical Growth: VSee Health, Inc. has experienced growth driven by the increasing adoption of telehealth and the unique value proposition of its telepresence robotics in healthcare settings. The company has likely seen increased demand following the global pandemic.
Future Projections: Future growth is expected to be driven by the continued expansion of the telehealth market, the increasing need for remote medical consultations, and potential new product developments. Analyst projections for privately held companies are not typically available.
Recent Initiatives: Recent initiatives likely involve enhancing their telehealth platform, expanding their robot's capabilities, forming strategic partnerships with healthcare providers, and exploring new market segments.
Summary
VSee Health, Inc. is a specialized player in the growing telehealth and telepresence robotics market, leveraging its integrated hardware and software solutions for healthcare. Its strength lies in its focused approach and pioneering technology in remote patient interaction. The company needs to navigate increasing competition and potential pricing pressures while capitalizing on the expanding demand for remote healthcare services and exploring strategic partnerships.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company website (general information)
- Industry reports on telehealth and robotics markets
- Publicly available news and press releases
- Third-party market research firms for competitor and market share estimates
Disclaimers:
This analysis is based on publicly available information and general industry knowledge. As VSee Health, Inc. is a privately held company, detailed financial performance, precise market share figures, and specific internal strategic data are not available, impacting the completeness of the analysis. Investment decisions should be made after consulting with a qualified financial advisor and conducting thorough due diligence.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About VSee Health, Inc.
Exchange NASDAQ | Headquaters Newton, MA, United States | ||
IPO Launch date 2021-12-31 | Co-CEO & Chairman of the Board Dr. Milton Chen Ph.D. | ||
Sector Healthcare | Industry Health Information Services | Full time employees 154 | Website https://www.vseehealth.com |
Full time employees 154 | Website https://www.vseehealth.com | ||
VSee Health, Inc. provides telehealth care solutions in the United States. The company offers iDoc Telehealth solutions that treat and coordinate care for acutely ill patients in the neurointensive care, cardiac intensive care, and intensive care units for stroke, spinal cord, brain trauma, and other neurological conditions. It also provides telehealth software building blocks, such as patient engagement, clinician staffing, remote physical exam and remote patient monitoring, and AI for telesitter and telenursing solutions; data connectors; and workflow templates. The company distributes its products through third-party resellers and affiliated hospitals, as well as sales executives. VSee Health, Inc. is headquartered in Newton, Massachusetts.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

